Precise Infliximab Exposure and Pharmacodynamic Control
Condition: Crohn Disease Interventions: Device: RoadMAB; Drug: Infliximab Sponsors: Children's Hospital Medical Center, Cincinnati; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2022 Category: Research Source Type: clinical trials